QUEST informs readers of the latest advances in urologic prostate cancer research, especially detection, prevention, and treatment.

success text

Signs of Success

Dr. Catalona is presenting the case for early detection of prostate cancer at medical conferences across the United States. QUEST is including information from his presentation in this issue and in upcoming issues.

Read More
family1

Identifying Men Susceptible to Prostate Cancer

To facilitate prostate cancer gene mapping and identification, the ICPCG was established in 2002 Dr. Catalona will be a co-investigator for a prostate cancer susceptibility study sponsored by ICPCG, the International Consortium for Prostate Cancer Genetics. (William Isaacs, PhD, Johns…

Read More

Subscribe to Quest

"*" indicates required fields

Email

This email address is only for subscribing or unsubscribing to or from Quest. Dr. Catalona cannot respond to questions concerning your Personal Health Information (PHI) that could identify you as an individual. This is a "cyber-security measure" for your protection that will help prevent anyone from legally or illegally accessing your personal health information.

Delivery Method (How do you want to receive your Quest publication?)*
Address*